UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)
 
June 18, 2009
 
CERADYNE, INC.
(Exact name of registrant as specified in its charter)

 

Delaware
 
000-13059
 
33-0055414
(State or other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

     
3169 Red Hill Avenue, Costa Mesa, CA
 
92626
(Address of Principal Executive Offices)
 
(Zip Code)

Registrant's telephone number, including area code:  (714) 549-0421
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Exhibit Index on page 4
 
 
 


 


Item 7.01  Regulation FD Disclosure.
 
On June 18, 2009, Ceradyne, Inc. issued a press release announcing receipt of an $8.3 million delivery order from the U.S. Marine Corps, Quantico, Virginia. This order is for Enhanced Small Arms Protective Inserts (ESAPI). The delivery order is against a larger Indefinite Delivery/Indefinite Quantity (ID/IQ) contract previously announced. A copy of this press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.
 
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
 


Item 9.01 Financial Statements and Exhibits.


(d)  Exhibits.

Exhibit Number
Description
99.1
Press release of Ceradyne, Inc. dated June 18, 2009.
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 
 
 
 
 

 


 
2

 


 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
CERADYNE, INC.
June 22, 2009
By:           /s/ Jerrold J. Pellizzon
 
Jerrold J. Pellizzon
 
Chief Financial Officer and Secretary
 
 
 
 
 
 
 
 

 

 

 

 

 

 

 

 

 
3

 

EXHIBIT INDEX
 
Exhibit Number
Description
99.1
Press release of Ceradyne, Inc. dated June 18, 2009.


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
 














 








 


Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Ceradyne, Inc. (MM) Charts.
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Ceradyne, Inc. (MM) Charts.